Kazia Raises A$4.0 Million to Progress R D Programs
SYDNEY, Oct. 28, 2019 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce the completion of a placement of ten million new fully paid ordinary shares in the Company (New Shares) to institutio...
Authors: LATEST ASIANET NEWS RELEASES